The Royal College of Psychiatrists
Royal College of Psychiatrists publish a wide range of books on mental health for both psychiatrists and the general public, along withtheir flagship journal the British Journal of Psychiatry.
View Rights PortalYour Search Results
-
Promoted Content
MedicineClinical Handbook of Psychotropic Drugs
by Ric M. Procyshyn, Kalyna Z. Bezchlibnyk-Butler, David D. Kim (Eds.)
Quick and comprehensive information on psychotropic drugs for adults. The “Clinical Handbook of Psychotropic Drugs” has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals Independent, unbiased, uptodate Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions …) for a quick overview of treatment options Succinct, bulleted information on all classes of medication: on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug Potential interactions and side effects summarized in comparison charts With instantly recognizable icons and in full color throughout, allowing you to fnd at a glance all the information you seek Clearly written patient information sheets available for download as printable PDF files
-
Promoted Content
Health & Personal DevelopmentClinical Handbook of Psychotropic Drugs for Children and Adolescents
by Dean Elbe, Kalyna Z. Bezchlibnyk-Butler, Adil S. Virani
Quick and comprehensive information on psychotropic drugs for children and adolescents. The “Clinical Handbook of Psychotropic Drugs for Children and Adolescents” is a unique resource to help you make the right choices about psychotropic medications for younger patients. The ffth edition of this widely acclaimed reference has been fully updated and expanded. • Updated information on psychiatric disorders in children and adolescents • U nique comparison charts (dosages, side effects, pharmacokinetics, interactions …) that allow you to see at a glance which medication is the most suitable for each patient • Instantly recognizable icons in full color throughout, a llowing you to quickly fnd all the information you seek • G eneral information on medications, availability, and indications • D rug action, dosing, pharmacokinetics, and related areas• Warnings and precautions • P atientrelated information, such as lab monitoring recommendations, nursing implications, and patient advice• Clearly written patient and caregiver information sheets as printable PDF fles
-
Trusted Partner
2021Psychotropic Drugs in General Practice
How to recognise, understand and treat patients successfully
by PD Dr. Daniel Schüpbach and Dr. Otto Dietmaier
The purpose of this book is to support general practitioners in finding the optimum, guideline-compliant therapy for their patients. The focus is on the clinical pictures of depression, psychosis as well as anxiety and sleep disorders and the handling of psychiatric emergencies. The reader will learn everything about the epidemiology, aetiology, diagnosis and medical treatment of these diseases, about switching therapy and about treatment in pregnancy and lactation. All the available psychotropic drugs and their pharmacological properties are described in detail – including key specific features of active substances and drug safety aspects. The table of substances in the appendix provides a clear summary of the information and simplifies the choice of the appropriate drug. The extras: - 13 factsheets with concise, summarised information to cope with tricky situations in the practice - The authors take the current treatment guidelines from Germany, Austria and Switzerland into account and name examples of proprietary medicinal products in the three countries.
-
Trusted Partner
Humanities & Social SciencesClinical Handbook of Psychotropic Drugs
by Ric M. Procyshyn / Kalyna Z. Bezchlibnyk-Butler / J. Joel Jeffries (Eds.)
The “Clinical Handbook of Psychotropic Drugs” has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.• Independent, unbiased, up-to-date• Packed with unique, easy-to-read comparison charts andtables (dosages, side effects, pharmacokinetics, interactions…)for a quick overview of treatment options• Succinct, bulleted information on all classes of medication:on- and off-label indications, (US FDA, Health Canada),recommended dosages, US and Canadian trade names, sideeffects, interactions, pharmacodynamics, precautions inthe young, the elderly, and pregnancy, nursing implications,and much more – all you need to know for each class of drug• Potential interactions and side effects summarized incomparison charts• With instantly recognizable icons and in full color throughout,allowing you to find at a glance all the information you seek• Clearly written patient information sheets available fordownload as printable PDF files This book is a must for everyone who needs an up-to-date, easyto- use, comprehensive summary of all the most relevant information about psychotropic drugs. Tables, graphs, and overviews make this handbook a practical tool for professionals. For:• psychiatrists und psychologists• physicians and pharmacists• nurses, and other mental health
-
Trusted Partner
2021Psychopharmacology and Psychopharmacotherapy.A Concise Guide
Training curriculum for medical specialists in psychiatry and psychotherapy
by Edited by Prof. Dr. Dipl.-Psych. Gerd Laux and Prof. Dr. Walter E. Müller
Psychotropic drugs have established their place in mental illnesses and form an important element of treatment. This textbook guides the selection of pharmacotherapy for a variety of psychological disorders such as depression, schizophrenia or dementia. The reader will learn, - How to use the various drugs in a targeted manner - The mechanisms of action on which they are based - Why side effects occur and how they can be dealt with. This book corresponds to the curriculum for the training of medical specialists in psychiatry and psychotherapy. It is an indispensable aid to anyone who uses psychotropic drugs!
-
Trusted Partner
MedicineJuly 2024On trial
Testing new drugs in psychiatry, 1940–1980
by Marietta Meier, Magaly Tornay, Mario König
The heroic story of the invention of antidepressants is a key part of the psychopharmaceutical turn. On Trial revolves around one of its pioneers, psychiatrist Roland Kuhn, who practiced in Münsterlingen, a state-run psychiatric hospital in Switzerland. Kuhn became famous for the 'discovery' of the first antidepressant, Tofranil, and more recently notorious for his numerous trials on often unsuspecting patients. Largely based on the extensive and previously inaccessible sources of Kuhn's private archive, the book delves into the early days of industry-sponsored clinical research in psychiatry. It examines how the clinic, patients, doctors, nursing staff, corporations, and authorities interacted in the trials. Conducted from the 1940s to 1980s, the Münsterlingen drug trials are historicised and situated in the period's evolving landscape of experimentation.
-
Trusted Partner
HOW TO CHANGE YOUR BODY
The Science of Interoception and Healing Through Connection to Yourself & Others
by Saga Briggs
Drawing from the latest research on interoception— which examines how our senseof self arises from subjective appraisal of bodily signals and how those appraisal habits develop in childhood—the book argues for a reframing of depression, anxiety, PTSD, and other “mental health” issues as social-emotional illnesses rooted in the body. Saga Briggs harnesses psychedelic science to show how interoception can be altered by psychoactive substances, providing an additional framework for understanding their therapeutic benefits.
-
Trusted Partner
The Secret Chief Revealed
Conversations with Leo Zeff, Pioneer in the Underground Psychedelic Therapy Movement
by Myron J. Stolaroff
Leo Zeff (1912 – 1988) was a pioneering psychedelic therapist and researcher focused on LSD, MDMA and other psychoactive drugs. He conducted much of his work and practice underground after psychedelics were declared illegal in the 1960s. By the time he turned 70, Zeff was single-handedly responsible for the introduction of psychedelic compounds in use globally among nearly 4,000 individual therapists/practitioners. The Secret Chief Revealed is written as a transcription of an interview conducted in the 1980s with Zeff about his research, studies, and practice with psychedelicassisted therapy. The revised 2nd edition maintains much of the 2nd edition release, including thoughtful contributions on Zeff’s lifework/research from other leaders in the psychedelic movement including Albert Hofmann, discoverer of LSD, psychedelic researcher and author, Stanislav Grov, a founder of transpersonal psychology, and Ann & Alexander Shulgin, renowned psychedelic researchers and authors, who also mention Zeff in Pihkal: A Chemical Love Story.
-
Trusted Partner
2024Intoxicating Drugs
Known and new psychoactive substances
by Prof. Dr. Niels Eckstein
Intoxicating? Intoxicating drugs are as old as mankind itself. Whether herbal or produced synthetically in a laboratory, their variety is almost limitless. And every year, more substances are added to the list. Niels Eckstein, who is a Professor of Drug Regulatory Affairs and Pharmacology and a long-standing expert in the narcotics scene, explores the abysses of the darknet and dealer hell, provides insider information, conducts interviews with dealers and producers, and offers profound insights into the bizarre, parallel world of intoxicating substances. At the same time, the author takes a thorough look at the chemistry of the different substance classes and the neurobiological basis of addiction. He also covers production and assesses the danger and addiction potential of designer drugs, BTM, NPS, medicinal drugs and doping substances. This book outlines the political and sociopolitical dimensions of the use of psychoactive substances, classifies them legally, describes risks, approaches, and help strategies, highlights routes out of drug problems and alternatives to drug prohibition, and comments on the opioid crisis in the United States and the „war on drugs.“ “I don‘t care how it‘s regulated: if he wants it and can pay for it, he gets it. If I get caught, I‘ll go to jail for a few years, whether it‘s for a kilo of coke, meph or testo, it doesn‘t matter.“ – In an interview with a dealer
-
Trusted Partner
April 2022Fritz, the Gorilla
Biography of a Fascinating Ape
by Jenny von Sperber
When Jenny von Sperber first met Fritz, the gorilla didn’t let her out of his sight. He was already over 50 years old then, but he was still extremely charismatic. One thing matters for the journalist: she wants to find out everything about Fritz’s life. Born in 1963, he was captured in the wild and came from Cameroon to Germany in 1966. At that time, apes were still regarded as a curiosity in zoos. When a ban was declared on the wild gorilla trade, Fritz was already a father of many youngsters. This fascinating gorilla-family saga not only recounts the eventful life of Fritz, but also shows the development in European zoos in handling wild animals. Nowadays, things have certainly improved. But there are still questions, for example, what does it do to us when we marvel at our closest relatives behind glass? And is it even still current to confine apes ... was it ever?
-
Trusted Partner
NATURE OF DRUGS
A Course on Pharmacology, Pharmacokinetics, Societal Responses and Social Impact Vol 1
by Alexander Shulgin
The Nature of Drugs is the story of humanity’s relationship with psychoactive substances from the perspective of a master psychopharmacologist. Derived from a lecture series by “Sasha” Shulgin at SFSU on the origins of drugs, how they work, how they are processed in the body, and how they affect our society. *Release Date Spring 2021
-
October 2021Pediatric Psychopharmacology for Primary Care
by Editor: Mark A. Riddle, MD
The revised and updated third edition of this best-selling resource provides primary care physicians with practice-tested, condition-specific treatment recommendations for various mental and psychiatric disorders or behavioral problems in children and adolescents. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications. Ease medication decision-making with a clear, straightforward methodology based on current research and clinical experience. This simple, systematic approach defines discrete levels of psychotropics and describes their group-specific roles and responsibilities in accordance with American Academy of Pediatrics policies. The accompanying digital tool offers instant access to authoritative answers on specific conditions and psychotropic medications.
-
MedicineJournal of Clinical Psychopharmacology
by Edited by Richard I Shader , David J Greenblatt MD
Bimonthly - 2013 Volume(s) - 31 www.psychopharmacology.com This leading publication in psychopharmacology offers a wide range of articles that report on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, medico-legal issues, and psychiatric effects of non-psychiatric drugs. The Journal keeps psychiatrists and psychiatric residents up-to-date on the latest clinical developments in the psychotropics, presenting the extensive coverage needed to keep up with every development in this fast-growing field.
-
Medicine1994American Journal of Therapeutics
by Edited by John C Somberg MD
Bimonthly - 2013 Volume(s) - 18 www.americantherapeutics.com The American Journal of Therapeutics is an indispensable resource for all prescribing physicians who want to access pharmacological developments in cardiology, infectious disease, oncology, anesthesiology, nephrology, toxicology and psychotropics without having to sift through stacks of medical journals. AJT features original articles on the latest therapeutic approaches as well as critical articles on the drug approval process, therapeutic reviews covering pharmacokinetics, regulatory affairs, pediatric clinical pharmacology, hypertension, metabolism, and drug delivery systems. Plus, clinical pharmacology and clinical therapeutics conferences update physicians and physicians-in-training on treating disease.
-
Humanities & Social SciencesJuly 2017Disrupt The Process of Drug Addiction
by Fredrick Norfleet
Reading "DISRUPT: THE PROCESS OF DRUG ADDICTION", will transform your life! Drug addiction is a process, consequently, when the process of addiction is disrupted benefits flourish. Moreover, just by opening the pages of this book, 'Disrupt: The Process of Drug Addiction' you have taken the first footstep to shifting your life domain. You should be proud of yourself for becoming an instrument to, "Disrupt: The Process of Drug Addiction".
-
Social groupsJanuary 1994Understanding and Preventing Violence, Volume 3
Social Influences
by Albert J. Reiss, Jr. and Jeffrey A. Roth, Editors, Panel on the Understanding and Control of Violent Behavior, National Research Council
This volume examines social influences on violent events and violent behavior, particularly concentrating on how the risks of violent criminal offending and victimization are influenced by communities, social situations, and individuals; the role of spouses and intimates; the differences in violence levels between males and females; and the roles of psychoactive substances in violent events.
-
MedicineInternational Clinical Psychopharmacology
An International Journal for Collaboration Between Research and Clinical Practice
by Edited by Stuart A Montgomery
Bimonthly - 2013 Volume(s) - 26 www.intclinpsychopharm.com International Clinical Psychopharmacology continues to maintain its high standing in publication of research and clinical practice within the field of psychopharmacology. This respected journal is largely concerned with psychotropic drugs, covering phase I-IV studies, clinical studies, side-effects and epidemiology. Papers deal with studies on both healthy volunteers and patients. Regular volume indexes make the journal an invaluable reference in the field.
-
Trusted Partner
Humanities & Social SciencesCHANGING OUR MINDS
Psychedelic Sacraments and the New Psychotherapy
by Don Lattin
A look at the recent history and credible prospects for using MDMA, psilocybin, and ayahuasca to treat mood disorders and promote spiritual well-being. Changing Our Minds is an experiential tour through a social, spiritual and scientific revolution that is redefining our culture’s often-confusing relationship with psychoactive substances.Veteran journalist Don Lattin chronicles the inspiring stories of pioneering neuroscientists, psychotherapists, spiritual guides and ordinary people seeking to live healthier lives by combining psychedelic drugs, psychotherapy, and the wise use of ancient plant medicines. In ground-breaking clinical trials, specially trained therapists employ Ecstasy (MDMA) to help U.S. veterans struggling with the psychological aftermath of war.Other psychiatrists in government-approved research offer psilocybin to alcoholics trying to get sober and cancer patients struggling with the existential distress of a life-threatening illness.Meanwhile, new imaging technology has enabled neuroscientists to map the psychedelic brain in real time, deepening our understanding of human consciousness. the essential primer for understanding and navigating this new consciousness-raising territory.
-
Health & Personal DevelopmentMay 2016The Drug Conversation
How to talk to your child about drugs
by Owen Bowden-Jones
The Drug Conversation is a guide for parents about how to raise the thorny issue of drugs with their children. It will help you begin a useful conversation about drugs with your child. The book provides information on the different types of psychoactive drugs available, their attractions and harms, how they work in the brain, and who uses them and why. It covers issues such as how to detect drug use, drug testing, synthetic drugs (‘legal highs’), accessing help, effective treatments and what to expect from professional medical services. The Drug Conversation also gives practical advice on how to prepare for and have a conversation about drugs with your child – including examples of actual conversations between parents and children. Case studies from the author’s own clinical practice are used to illustrate the main points. All parents will need this book at some stage. It will help you to feel properly informed about drugs, more confident in talking to your child, more able to keep drug-related problems from developing and better equipped to tackle problems if they do arise
-
Diseases & disordersJune 2004New Treatments for Addiction
Behavioral, Ethical, Legal, and Social Questions
by Henrick J. Harwood and Tracy G. Myers, Editors, Committee on Immunotherapies and Sustained-Release Formulations for Treating Drug Addiction, National Research Council
New and improved therapies to treat and protect against drug dependence and abuse are urgently needed. In the United States alone about 50 million people regularly smoke tobacco and another 5 million are addicted to other drugs. In a given year, millions of these individuals attemptâ€"with or without medical assistanceâ€"to quit using drugs, though relapse remains the norm. Furthermore, each year several million teenagers start smoking and nearly as many take illicit drugs for the first time. Research is advancing on promising new means of treating drug addiction using immunotherapies and sustained-release (depot) medications. The aim of this research is to develop medications that can block or significantly attenuate the psychoactive effects of such drugs as cocaine, nicotine, heroin, phencyclidine, and methamphetamine for weeks or months at a time. This represents a fundamentally new therapeutic approach that shows promise for treating drug addiction problems that were difficult to treat in the past. Despite their potential benefits, however, several characteristics of these new methods pose distinct behavioral, ethical, legal, and social challenges that require careful scrutiny. Such issues can be considered unique aspects of safety and efficacy that are fundamentally related to the distinct nature and properties of these new types of medications.
